GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients
- 31 December 2011
- journal article
- research article
- Published by Elsevier BV in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 29 (10), 735-758
- https://doi.org/10.1016/j.eimc.2011.05.022
Abstract
No abstract availableKeywords
This publication has 241 references indexed in Scilit:
- Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokineticsTransplant Infectious Disease, 2009
- Cytomegalovirus Immunoglobulin Decreases the Risk of Cytomegalovirus Infection but not Disease After Pediatric Lung TransplantationThe Journal of Heart and Lung Transplantation, 2009
- The Risk, Prevention, and Outcome of Cytomegalovirus After Pediatric Lung TransplantationTransplantation, 2009
- Vaccine Prevention of Maternal Cytomegalovirus InfectionNew England Journal of Medicine, 2009
- Expansion of Cytomegalovirus pp65 and IE-1 Specific Cytotoxic T Lymphocytes for Cytomegalovirus-Specific Immunotherapy Following Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2008
- Ganciclovir for Cytomegalovirus: a Call for Indefinite Prophylaxis in Lung TransplantationThe Journal of Heart and Lung Transplantation, 2008
- Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirusVaccine, 2007
- Safety and efficacy of prolonged cytomegalovirus prophylaxis with intravenous ganciclovir in pediatric and young adult lung transplant recipientsPediatric Transplantation, 2007
- Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjectsThe Journal of Experimental Medicine, 2005
- Guide to Development of Practice GuidelinesClinical Infectious Diseases, 2001